DAM
VRTX icon

Delta Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Delta Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$893 Hold
2
– – ﹤0.01% 565
2025
Q4 		$907 Hold
2
– – ﹤0.01% 570
2025
Q3 		$783 Hold
2
– – ﹤0.01% 582
2025
Q2 		$890 Hold
2
– – ﹤0.01% 566
2025
Q1 		$970 Hold
2
– – ﹤0.01% 569
2024
Q4 		$805 Hold
2
– – ﹤0.01% 584
2024
Q3 		$930 Hold
2
– – ﹤0.01% 584
2024
Q2 		$937 Hold
2
– – ﹤0.01% 592
2024
Q1 		$836 Hold
2
– – ﹤0.01% 610
2023
Q4 		$814 Buy
+2
New +$739 ﹤0.01% 623

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Delta Asset Management's VRTX Position: Q1 2026 in Review

Delta Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 2 shares worth $893. The position accounts for ﹤0.01% of the portfolio, ranked #565.

Delta Asset Management first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $970 in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Delta Asset Management held 2 shares of Vertex Pharmaceuticals worth $893 as of Q1 2026.
  • Delta Asset Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Delta Asset Management's portfolio in Q1 2026, its #565 holding.
  • Delta Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Delta Asset Management's Vertex Pharmaceuticals position peaked at $970 in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Delta Asset Management's 13F filing for Q1 2026, filed 11 May 2026.